{"pmid":32485164,"pmcid":"PMC7250783","title":"A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.","text":["A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.","Since December 2019, a novel coronavirus SARS-CoV-2 has emerged and rapidly spread throughout the world, resulting in a global public health emergency. The lack of vaccine and antivirals has brought an urgent need for an animal model. Human angiotensin-converting enzyme II (ACE2) has been identified as a functional receptor for SARS-CoV-2. In this study, we generated a mouse model expressing human ACE2 (hACE2) by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young and aged hACE2 mice sustained high viral loads in lung, trachea, and brain upon intranasal infection. Although fatalities were not observed, interstitial pneumonia and elevated cytokines were seen in SARS-CoV-2 infected-aged hACE2 mice. Interestingly, intragastric inoculation of SARS-CoV-2 was seen to cause productive infection and lead to pulmonary pathological changes in hACE2 mice. Overall, this animal model described here provides a useful tool for studying SARS-CoV-2 transmission and pathogenesis and evaluating COVID-19 vaccines and therapeutics.","Cell Host Microbe","Sun, Shi-Hui","Chen, Qi","Gu, Hong-Jing","Yang, Guan","Wang, Yan-Xiao","Huang, Xing-Yao","Liu, Su-Su","Zhang, Na-Na","Li, Xiao-Feng","Xiong, Rui","Guo, Yan","Deng, Yong-Qiang","Huang, Wei-Jin","Liu, Quan","Liu, Quan-Ming","Shen, Yue-Lei","Zhou, Yong","Yang, Xiao","Zhao, Tong-Yan","Fan, Chang-Fa","Zhou, Yu-Sen","Qin, Cheng-Feng","Wang, You-Chun","32485164"],"abstract":["Since December 2019, a novel coronavirus SARS-CoV-2 has emerged and rapidly spread throughout the world, resulting in a global public health emergency. The lack of vaccine and antivirals has brought an urgent need for an animal model. Human angiotensin-converting enzyme II (ACE2) has been identified as a functional receptor for SARS-CoV-2. In this study, we generated a mouse model expressing human ACE2 (hACE2) by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young and aged hACE2 mice sustained high viral loads in lung, trachea, and brain upon intranasal infection. Although fatalities were not observed, interstitial pneumonia and elevated cytokines were seen in SARS-CoV-2 infected-aged hACE2 mice. Interestingly, intragastric inoculation of SARS-CoV-2 was seen to cause productive infection and lead to pulmonary pathological changes in hACE2 mice. Overall, this animal model described here provides a useful tool for studying SARS-CoV-2 transmission and pathogenesis and evaluating COVID-19 vaccines and therapeutics."],"journal":"Cell Host Microbe","authors":["Sun, Shi-Hui","Chen, Qi","Gu, Hong-Jing","Yang, Guan","Wang, Yan-Xiao","Huang, Xing-Yao","Liu, Su-Su","Zhang, Na-Na","Li, Xiao-Feng","Xiong, Rui","Guo, Yan","Deng, Yong-Qiang","Huang, Wei-Jin","Liu, Quan","Liu, Quan-Ming","Shen, Yue-Lei","Zhou, Yong","Yang, Xiao","Zhao, Tong-Yan","Fan, Chang-Fa","Zhou, Yu-Sen","Qin, Cheng-Feng","Wang, You-Chun"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32485164","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.chom.2020.05.020","keywords":["sars-cov-2","angiotensin-converting enzyme ii","hace2-ki/nifdc","mouse model","pathogenesis"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668704334399930368,"score":9.490897,"similar":[{"pmid":32380511,"title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.","text":["The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.","Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) caused the corona virus disease 2019 (COVID-19) cases in China and has become a public health emergency of international concern(1). Because angiotensin-converting enzyme 2 (ACE2) is the cell entry receptor of SARS-CoV(5), we used transgenic mice bearing human ACE2 and infected with SARS-CoV-2 to study the pathogenicity of the virus. Weight loss and virus replication in lung were observed in hACE2 mice infected with SARS-CoV-2. The typical histopathology was interstitial pneumonia with infiltration of significant macrophages and lymphocytes into the alveolar interstitium, and accumulation of macrophages in alveolar cavities. Viral antigens were observed in the bronchial epithelial cells, macrophages and alveolar epithelia. The phenomenon was not found in wild-type mice with SARS-CoV-2 infection. Notably, we have confirmed the pathogenicity of SARS-CoV-2 in hACE2 mice. The mouse model with SARS-CoV-2 infection will be valuable for evaluating antiviral therapeutics and vaccines as well as understanding the pathogenesis of COVID-19.","Nature","Bao, Linlin","Deng, Wei","Huang, Baoying","Gao, Hong","Liu, Jiangning","Ren, Lili","Wei, Qiang","Yu, Pin","Xu, Yanfeng","Qi, Feifei","Qu, Yajin","Li, Fengdi","Lv, Qi","Wang, Wenling","Xue, Jing","Gong, Shuran","Liu, Mingya","Wang, Guanpeng","Wang, Shunyi","Song, Zhiqi","Zhao, Linna","Liu, Peipei","Zhao, Li","Ye, Fei","Wang, Huijuan","Zhou, Weimin","Zhu, Na","Zhen, Wei","Yu, Haisheng","Zhang, Xiaojuan","Guo, Li","Chen, Lan","Wang, Conghui","Wang, Ying","Wang, Xinming","Xiao, Yan","Sun, Qiangming","Liu, Hongqi","Zhu, Fanli","Ma, Chunxia","Yan, Lingmei","Yang, Mengli","Han, Jun","Xu, Wenbo","Tan, Wenjie","Peng, Xiaozhong","Jin, Qi","Wu, Guizhen","Qin, Chuan","32380511"],"abstract":["Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) caused the corona virus disease 2019 (COVID-19) cases in China and has become a public health emergency of international concern(1). Because angiotensin-converting enzyme 2 (ACE2) is the cell entry receptor of SARS-CoV(5), we used transgenic mice bearing human ACE2 and infected with SARS-CoV-2 to study the pathogenicity of the virus. Weight loss and virus replication in lung were observed in hACE2 mice infected with SARS-CoV-2. The typical histopathology was interstitial pneumonia with infiltration of significant macrophages and lymphocytes into the alveolar interstitium, and accumulation of macrophages in alveolar cavities. Viral antigens were observed in the bronchial epithelial cells, macrophages and alveolar epithelia. The phenomenon was not found in wild-type mice with SARS-CoV-2 infection. Notably, we have confirmed the pathogenicity of SARS-CoV-2 in hACE2 mice. The mouse model with SARS-CoV-2 infection will be valuable for evaluating antiviral therapeutics and vaccines as well as understanding the pathogenesis of COVID-19."],"journal":"Nature","authors":["Bao, Linlin","Deng, Wei","Huang, Baoying","Gao, Hong","Liu, Jiangning","Ren, Lili","Wei, Qiang","Yu, Pin","Xu, Yanfeng","Qi, Feifei","Qu, Yajin","Li, Fengdi","Lv, Qi","Wang, Wenling","Xue, Jing","Gong, Shuran","Liu, Mingya","Wang, Guanpeng","Wang, Shunyi","Song, Zhiqi","Zhao, Linna","Liu, Peipei","Zhao, Li","Ye, Fei","Wang, Huijuan","Zhou, Weimin","Zhu, Na","Zhen, Wei","Yu, Haisheng","Zhang, Xiaojuan","Guo, Li","Chen, Lan","Wang, Conghui","Wang, Ying","Wang, Xinming","Xiao, Yan","Sun, Qiangming","Liu, Hongqi","Zhu, Fanli","Ma, Chunxia","Yan, Lingmei","Yang, Mengli","Han, Jun","Xu, Wenbo","Tan, Wenjie","Peng, Xiaozhong","Jin, Qi","Wu, Guizhen","Qin, Chuan"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32380511","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1038/s41586-020-2312-y","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666597097307111424,"score":510.4402},{"pmid":32444876,"title":"Transmission of SARS-CoV-2 via close contact and respiratory droplets among hACE2 mice.","text":["Transmission of SARS-CoV-2 via close contact and respiratory droplets among hACE2 mice.","We simulated three transmission modes including close contact, respiratory droplets and aerosol routes in labratory. SARS-CoV-2 can be highly transmitted among naive hACE2 mice via close contact because 7/13 naive hACE2 mice were SARS-CoV-2 antibodies seropositivity on 14 days after introduced into the same cage with 3 infected-hACE2 mice. For respiratory droplets, SARS-CoV-2 antibodies from 3/10 naive hACE2 mice showed seropositivity on 14 days after introduced into the grids separated same cage from 3 infected-hACE2 mice. Additionally, hACE2 mice cannot be experimentally infected via aerosol inoculation until continued up to 25 min with high virus concentrations.","J Infect Dis","Bao, Linlin","Gao, Hong","Deng, Wei","Lv, Qi","Yu, Haisheng","Liu, Mingya","Yu, Pin","Liu, Jiangning","Qu, Yajin","Gong, Shuran","Lin, Kaili","Qi, Feifei","Xu, Yanfeng","Li, Fengli","Xiao, Chong","Xue, Jing","Song, Zhiqi","Xiang, Zhiguang","Wang, Guanpeng","Wang, Shunyi","Liu, Xing","Zhao, Wenjie","Han, Yunlin","Wei, Qiang","Qin, Chuan","32444876"],"abstract":["We simulated three transmission modes including close contact, respiratory droplets and aerosol routes in labratory. SARS-CoV-2 can be highly transmitted among naive hACE2 mice via close contact because 7/13 naive hACE2 mice were SARS-CoV-2 antibodies seropositivity on 14 days after introduced into the same cage with 3 infected-hACE2 mice. For respiratory droplets, SARS-CoV-2 antibodies from 3/10 naive hACE2 mice showed seropositivity on 14 days after introduced into the grids separated same cage from 3 infected-hACE2 mice. Additionally, hACE2 mice cannot be experimentally infected via aerosol inoculation until continued up to 25 min with high virus concentrations."],"journal":"J Infect Dis","authors":["Bao, Linlin","Gao, Hong","Deng, Wei","Lv, Qi","Yu, Haisheng","Liu, Mingya","Yu, Pin","Liu, Jiangning","Qu, Yajin","Gong, Shuran","Lin, Kaili","Qi, Feifei","Xu, Yanfeng","Li, Fengli","Xiao, Chong","Xue, Jing","Song, Zhiqi","Xiang, Zhiguang","Wang, Guanpeng","Wang, Shunyi","Liu, Xing","Zhao, Wenjie","Han, Yunlin","Wei, Qiang","Qin, Chuan"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32444876","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/infdis/jiaa281","keywords":["sars-cov-2","aerosol","close contact","hace2 transgenic mice","respiratory droplets","transmission routes"],"locations":["labratory"],"topics":["Transmission"],"weight":1,"_version_":1667600475921317888,"score":426.93948},{"pmid":32498696,"pmcid":"PMC7269898","title":"COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice.","text":["COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice.","Coronavirus disease 2019 (COVID-19) is a declared pandemic that is spreading all over the world at a dreadfully fast rate. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the pathogen of COVID-19, infects the human body using angiotensin-converting enzyme 2 (ACE2) as a receptor identical to the severe acute respiratory syndrome (SARS) pandemic that occurred in 2002-2003. SARS-CoV-2 has a higher binding affinity to human ACE2 than to that of other species. Animal models that mimic the human disease are highly essential to develop therapeutics and vaccines against COVID-19. Here, we review transgenic mice that express human ACE2 in the airway and other epithelia and have shown to develop a rapidly lethal infection after intranasal inoculation with SARS-CoV, the pathogen of SARS. This literature review aims to present the importance of utilizing the human ACE2 transgenic mouse model to better understand the pathogenesis of COVID-19 and develop both therapeutics and vaccines.","Hum Genomics","Lutz, Cathleen","Maher, Leigh","Lee, Charles","Kang, Wonyoung","32498696"],"abstract":["Coronavirus disease 2019 (COVID-19) is a declared pandemic that is spreading all over the world at a dreadfully fast rate. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the pathogen of COVID-19, infects the human body using angiotensin-converting enzyme 2 (ACE2) as a receptor identical to the severe acute respiratory syndrome (SARS) pandemic that occurred in 2002-2003. SARS-CoV-2 has a higher binding affinity to human ACE2 than to that of other species. Animal models that mimic the human disease are highly essential to develop therapeutics and vaccines against COVID-19. Here, we review transgenic mice that express human ACE2 in the airway and other epithelia and have shown to develop a rapidly lethal infection after intranasal inoculation with SARS-CoV, the pathogen of SARS. This literature review aims to present the importance of utilizing the human ACE2 transgenic mouse model to better understand the pathogenesis of COVID-19 and develop both therapeutics and vaccines."],"journal":"Hum Genomics","authors":["Lutz, Cathleen","Maher, Leigh","Lee, Charles","Kang, Wonyoung"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32498696","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1186/s40246-020-00272-6","keywords":["angiotensin-converting enzyme 2 (ace2)","covid-19","coronavirus","sars-cov-2","transgenic mouse"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668890966360064001,"score":373.8204},{"pmid":32265331,"pmcid":"PMC7157776","title":"Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection.","text":["Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection.","Middle East respiratory syndrome coronavirus (MERS-CoV) can cause severe and fatal acute respiratory disease in humans and remains endemic in the Middle East since first being identified in 2012. There are currently no approved vaccines or therapies available for MERS-CoV. In this study, we evaluated parainfluenza virus 5 (PIV5)-based vaccine expressing the MERS-CoV envelope spike protein (PIV5/MERS-S) in a human DPP4 knockin C57BL/6 congenic mouse model (hDPP4 KI). Following a single-dose intranasal immunization, PIV5-MERS-S induced neutralizing antibody and robust T cell responses in hDPP4 KI mice. A single intranasal administration of 10(4) PFU PIV5-MERS-S provided complete protection against a lethal challenge with mouse-adapted MERS-CoV (MERSMA6.1.2) and improved virus clearance in the lung. In comparison, single-dose intramuscular immunization with 10(6) PFU UV-inactivated MERSMA6.1.2 mixed with Imject alum provided protection to only 25% of immunized mice. Intriguingly, an influx of eosinophils was observed only in the lungs of mice immunized with inactivated MERS-CoV, suggestive of a hypersensitivity-type response. Overall, our study indicated that PIV5-MERS-S is a promising effective vaccine candidate against MERS-CoV infection.IMPORTANCE MERS-CoV causes lethal infection in humans, and there is no vaccine. Our work demonstrates that PIV5 is a promising vector for developing a MERS vaccine. Furthermore, success of PIV5-based MERS vaccine can be employed to develop a vaccine for emerging CoVs such as SARS-CoV-2, which causes COVID-19.","mBio","Li, Kun","Li, Zhuo","Wohlford-Lenane, Christine","Meyerholz, David K","Channappanavar, Rudragouda","An, Dong","Perlman, Stanley","McCray, Paul B Jr","He, Biao","32265331"],"abstract":["Middle East respiratory syndrome coronavirus (MERS-CoV) can cause severe and fatal acute respiratory disease in humans and remains endemic in the Middle East since first being identified in 2012. There are currently no approved vaccines or therapies available for MERS-CoV. In this study, we evaluated parainfluenza virus 5 (PIV5)-based vaccine expressing the MERS-CoV envelope spike protein (PIV5/MERS-S) in a human DPP4 knockin C57BL/6 congenic mouse model (hDPP4 KI). Following a single-dose intranasal immunization, PIV5-MERS-S induced neutralizing antibody and robust T cell responses in hDPP4 KI mice. A single intranasal administration of 10(4) PFU PIV5-MERS-S provided complete protection against a lethal challenge with mouse-adapted MERS-CoV (MERSMA6.1.2) and improved virus clearance in the lung. In comparison, single-dose intramuscular immunization with 10(6) PFU UV-inactivated MERSMA6.1.2 mixed with Imject alum provided protection to only 25% of immunized mice. Intriguingly, an influx of eosinophils was observed only in the lungs of mice immunized with inactivated MERS-CoV, suggestive of a hypersensitivity-type response. Overall, our study indicated that PIV5-MERS-S is a promising effective vaccine candidate against MERS-CoV infection.IMPORTANCE MERS-CoV causes lethal infection in humans, and there is no vaccine. Our work demonstrates that PIV5 is a promising vector for developing a MERS vaccine. Furthermore, success of PIV5-based MERS vaccine can be employed to develop a vaccine for emerging CoVs such as SARS-CoV-2, which causes COVID-19."],"journal":"mBio","authors":["Li, Kun","Li, Zhuo","Wohlford-Lenane, Christine","Meyerholz, David K","Channappanavar, Rudragouda","An, Dong","Perlman, Stanley","McCray, Paul B Jr","He, Biao"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32265331","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1128/mBio.00554-20","keywords":["covid-19","mers","coronavirus","vaccine"],"locations":["Imject"],"e_drugs":["aluminum sulfate"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138491985068032,"score":348.37933},{"pmid":32405877,"title":"A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?","text":["A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?","INTRODUCTION: COVID-19 presentation may include a profound increase in cytokines and associated pneumonia, rapidly progressing to acute respiratory distress syndrome (ARDS). This so-called cytokine storm often leads to refractory edema, respiratory arrest, and death. At present, anti-IL-6, antiviral therapy, convalescent plasma, hydroxychloroquine, and azithromycin among others are being investigated as potential treatments for COVID-19. As the disease etiology and precise therapeutic interventions are still not definitively defined, we wanted to review the roles that complement and the contact system may have in either the treatment or pathogenesis of the disease. METHODS: We searched the recent literature (PubMed) on complement and coronavirus; contact system and coronavirus; bradykinin and coronavirus; and angiotensin receptor and coronavirus. The manuscript complies with ethics guidelines and was deemed exempt from institutional review board approval according to Human Subjects Protection Office guidelines. RESULTS: Mouse models are available for the study of coronavirus and complement. Although complement is effective in protecting against many viruses, it does not seem to be protective against coronavirus. C3 knockout mice infected with SARS-CoV had less lung disease than wild-type mice, suggesting that complement may play a role in coronavirus pathogenesis. Some evidence suggests that the observed pulmonary edema may be bradykinin-induced and could be the reason that corticosteroids, antihistamines, and other traditional interventions for edema are not effective. Angiotensin-converting enzyme 2 (ACE2) is a co-receptor for SARS-CoV-2, and studies thus far have not concluded a benefit or risk associated with the use of either ACE-inhibitors or angiotensin receptor antagonists. Activation of complement and the contact system, through generation of bradykinin, may play a role in the SARS-CoV-2-induced pulmonary edema, and our search suggests that further work is necessary to confirm our suspicions.","Pulm Ther","Maglakelidze, Natella","Manto, Kristen M","Craig, Timothy J","32405877"],"abstract":["INTRODUCTION: COVID-19 presentation may include a profound increase in cytokines and associated pneumonia, rapidly progressing to acute respiratory distress syndrome (ARDS). This so-called cytokine storm often leads to refractory edema, respiratory arrest, and death. At present, anti-IL-6, antiviral therapy, convalescent plasma, hydroxychloroquine, and azithromycin among others are being investigated as potential treatments for COVID-19. As the disease etiology and precise therapeutic interventions are still not definitively defined, we wanted to review the roles that complement and the contact system may have in either the treatment or pathogenesis of the disease. METHODS: We searched the recent literature (PubMed) on complement and coronavirus; contact system and coronavirus; bradykinin and coronavirus; and angiotensin receptor and coronavirus. The manuscript complies with ethics guidelines and was deemed exempt from institutional review board approval according to Human Subjects Protection Office guidelines. RESULTS: Mouse models are available for the study of coronavirus and complement. Although complement is effective in protecting against many viruses, it does not seem to be protective against coronavirus. C3 knockout mice infected with SARS-CoV had less lung disease than wild-type mice, suggesting that complement may play a role in coronavirus pathogenesis. Some evidence suggests that the observed pulmonary edema may be bradykinin-induced and could be the reason that corticosteroids, antihistamines, and other traditional interventions for edema are not effective. Angiotensin-converting enzyme 2 (ACE2) is a co-receptor for SARS-CoV-2, and studies thus far have not concluded a benefit or risk associated with the use of either ACE-inhibitors or angiotensin receptor antagonists. Activation of complement and the contact system, through generation of bradykinin, may play a role in the SARS-CoV-2-induced pulmonary edema, and our search suggests that further work is necessary to confirm our suspicions."],"journal":"Pulm Ther","authors":["Maglakelidze, Natella","Manto, Kristen M","Craig, Timothy J"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405877","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s41030-020-00118-5","keywords":["angiotensin receptors","bradykinin","covid-19","complement","contact system","coronavirus"],"e_drugs":["Hydroxychloroquine","Azithromycin"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666950579738378240,"score":287.4598}]}